Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
A Standard patent application filed on 19 February 2002 credited to Slassi, Abdelmalik ; Van Wagenen, Bradford ; Smith, Daryl L. ; Stormann, Thomas M. ; Isaac, Methvin Benjamin ; Moe, Scott T. ; Sheehan, Susan M. ; McLeod, Donald A.

Details

Application number :

2002306517  

Application type :

Standard  

Application status :

CEASED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists  

Inventor :

Slassi, Abdelmalik ; Van Wagenen, Bradford ; Smith, Daryl L. ; Stormann, Thomas M. ; Isaac, Methvin Benjamin ; Moe, Scott T. ; Sheehan, Susan M. ; McLeod, Donald A.  

Agent name :

Davies Collison Cave  

Address for service :

1 Nicholson Street Melbourne VIC 3000 Australia  

Filing date :

19 February 2002  

Associated companies :

 

Applicant name :

AstraZeneca AB  

Applicant address :

SE-151 85 Sodertalje Sweden  

Old name :

NPS Pharmaceuticals, Inc.  

Original Source :

Go  

Related Patents

• Heteropolycyclic compounds and their use as metabotropic glutamate...
• Additional heteropolycyclic compounds and their use as metabotropic...

Same Inventor

• Heteropolycyclic compounds and their use as metabotropic glutamate...